Advertisement

Topics

FDA Approves Combination for Therapy-Related Acute Myeloid Leukemia

12:15 EDT 4 Aug 2017 | Cancer Networks

The FDA has approved a fixed combination of cytarabine and daunorubicin (Vyxeos) for the treatment of newly diagnosed therapy-related acute myeloid leukemia (AML) as well as AML with myelodysplasia-related changes.

Original Article: FDA Approves Combination for Therapy-Related Acute Myeloid Leukemia

NEXT ARTICLE

More From BioPortfolio on "FDA Approves Combination for Therapy-Related Acute Myeloid Leukemia"

Quick Search
Advertisement
 

Relevant Topic

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...